To study the effective therapeutic bioavailability of Atazanavir Sulfate (ATV), administered singly or in combination with Ritonavir, a cost effective and rapid method is required. In order to assess an in-depth study, it is primarily thought prudent to develop an effective analytical method for estimation of ATV in marketed dosage forms. The present work is to develop a simple and precise analytical method for in depth evaluation of therapeutic efficacy of ATV. The novelty of the method shows linearity in the concentration range of 10-100µg/mL at two wavelengths, i.e. 254nm and 284nm respectively. The chromatographic system consists of HiQSil C18HS column; an isocratic mobile phase consisted of methanol and tetrahydrofuran (95:5 v/v). The developed method is validated according to ICH guidelines in capsule dosage form. Validation of the developed method shows good result in range, linearity, accuracy and precision. Student's t-test was used to correlate the two methods and applied to raw materials and capsule dosage form.
Introduction
Atazanavir (ATV) is the 7 th Protease Inhibitor used in the treatment of HIV Type II infection (Fig 1) 1 . It is an azapeptide having chemical formula (3S,8S,9S,12S) -3,12 -Bis (1,1dimethylethyl) -8 -hydroxyl -4,11 -dioxo -9 -(phenylmethyl) -6 -[[4 -(2pyridinyl)phenyl]methyl] -2,5,6,10,13 pentaazatetra decanedioic acid dimethyl ester, sulphate. In some literature ATV is reported as poorly water soluble and is known substrate of both hepatic metabolizing enzyme Cytochrome 450 (CYP3A) and intestinal drug efflux pump, P-glycoprotein (Pgp), so having low oral bioavailability 2 . So to avoid this problem low dose of Ritonavir (RTV) is administered as booster. So clinically low dose of RTV has been used to increase the bioavailability of other PI [3] [4] [5] . It is also reported RTV is not only a potent inhibitor, but also a potent inducer of CYP3A and Pgp with chronic use 6, 7 .
The contradictory reports regarding ATV inspired to develop an analytical method for an in -depth study of therapeutic bioavailability of ATV administered singly or in combination in in-vitro condition. ATV has been determined in blood serum 8 , blood plasma [9] [10] [11] , CSF 12 and biological cells 12, 13 . No method is reported for pharmaceutical dosage form. So a simple, rapid, cost effective and extremely precise analytical method is developed to estimate much costlier 2 nd line drug (ATV) for treatment of HIV Type II infection. The developed method follows the linearity at two wavelengths, i.e. 254nm and 284nm. The method is validated according to ICH guidelines 14 .
Experimental
Chemicals and Reagents ATV (Atazanavir Sulfate) was obtained from Cipla Pvt. Ltd. (Mumbai, India). Methanol and Tetrahydrofuran for HPLC were procured from Merck (Mumbai, India). Commercially available capsule formulations are collected, Atavir 300 (Cipla) and Atazor 200 (Emcure).
Chromatographic System and Conditions
The chromatographic system consisted of a Jasco (Japan) chromatograph equipped with an LC -Net II/ADC, an MU -2010 Plus PDA Detector, a PU -2089 Plus quaternary pump, an online degasser and a Rheodyne model 7725 injector valve with 20µl sample loop. The chromatograph is coupled with "Chrompass" software. Separation of ATV was done on a HiQ Sil C18HS (250mm x 4.6mm, Particle size 5µm) under reverse phase partition chromatographic conditions. The isocratic mobile phase consisted of a mixture of Methanol and Tetrahydrofuran (95:5, v/v) and was filtered through 0.45µm nylon filter membrane before use. The flow rate was 1mL/min and the assay run time was 10mins. Absorbance was measured at 254nm and 284nm.
Preparation of Stock Solution, Working Solution and Standard Calibration Curve
A stock solution of 400µg/ml of ATV was prepared in Methanol. The stock solution was diluted further with methanol to obtain six working solutions with concentrations of 100-10µg/mL. The prepared samples were also filtered through 0.45µm nylon filter membrane before injection. The standard calibration curve was plotted by AUC Vs Concentration at 254nm and 284nm.
Sample Preparation
Commercially marketed sample of Atavir 300 (Cipla) and Atazor 200 (Emcure) were purchased. Twenty capsules were weighed carefully, equivalent amount of solid content was weighed accurately. Weighed amount was dissolved in methanol to prepare the sample solution of concentration 400µg/mL. The sample was filtered through Whatman filter paper No 41, then through 0.45µm nylon filter membrane before injection.
Method Validation
The developed methods were validated according to ICH guidelines 14 . The validation parameters were linearity, specificity, accuracy, precision, Limit of detection (LOD), Limit of Quantification (LOQ) and Robustness at both the wavelengths (Method A and B). Intraday and Inter-day precision values were estimated by assaying the pharmaceutical dosage form containing three different concentrations of ATV six times on the same day and on three different days. Accuracy was determined by recovery study by standard addition method. The standard was added to a predetermined concentration at 25%, 50% and 100% level. The LOD and LOQ was determined by using equation (1) and (2) respectively
where 'σ' is the standard deviation of y-intercept and 'S' is the slope of calibration curve.
Statistical Analysis
To correlate the difference between the two developed methods of HPLC, six different samples were taken from two different brands and quantification was done simultaneously.
To test difference between the proposed HPLC methods statistical tests were performed for the level of confidence 95% (P = 0.05).Two way ANOVA and Student's t -test were applied to test the significant difference between both the methods.
Result and Discussion

Method Development
To develop an efficient and reproducible method for assay of ATV in pharmaceutical dosage form many solvent system combinations were tried, like methanol, water, acetonitrile and tetrahydrofuran. Generally the retention time of PIs is dependent on pH of the solvent system 15 . To avoid the tedious preparation and maintenance of buffers, the pure organic solvents were chosen. So the solvent, methanol and tetrahydrofuran in the ratio 95:5 were selected, which is easy and cost-effective. Isocratic mode was preferred to gradient elution as it requires long re-equilibrium time, perfect mixing. The analysis was done at normal room temperature. Another major advantage of this method is that the analysis can be done at two different wavelengths with excellent accuracy and precision. The two wavelengths were 254nm and 284nm.At these both the wavelengths the chromatographic separation was very good, following very good linearity. The method was found to be accurate, precise and specific at both the wavelengths (Figure 2 and 3 ). Using these chromatographic conditions, the retention time of ATV at both the wavelengths was found to be 3.227 ±0.014 minutes.
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Calibration Curve and Linearity ATV showed good correlation coefficient in concentration range of 10-100µg/mL in method A and B respectively. A six point calibration standard curve of ATV was plotted ranging from 10µg/mL-100µg/mL standard working solutions containing ATV in triplicate for method A and B (Table 1) . For both the methods linearity of calibration graphs was validated by high value of correlation of coefficient and the S.D. for intercept value was less than 2%. No significant difference was observed in the slopes of standard curves. 
Accuracy
Both the proposed methods when used for extraction and subsequent quantification of ATV in preanalyzed sample by standard addition method at the level of 25, 50 and 100%. In both the methods assay of each concentration were repeated for three times. The mean recoveries for ATV from the marketed formulation are listed in Table 2 . 
Precision
The intra-day and inter-day precision were determined by assaying the tablets in triplicate for three different concentrations in a day and for consecutive six days and expressed as relative standard deviation. The relative standard deviations were below 2%, which signifies the precision of both the methods (Table 3) . 
Limit of Detection (LOD) and Limit of Quantification (LOQ)
The LOD and LOQ values were found to be 1.9µg/mL, 0.2475µg/mL and 5.7µg/mL, 0.75µg/mL for method A and B at 254nm and 284nm respectively.
Robustness
To evaluate method robustness few parameters were varied. The variation was done in composition of solvent system (± 2% of organic phase), flow rate (± 0.2 mL/min), wavelength (± 2 nm). Robustness was done in triplicate at a concentration level of 100µg/mL and 200µg/mL for ATV in method A and B respectively and the S.D of retention time, capacity factor and tailing factor were calculated (Table 4) .
Specificity
To evaluate the specificity of the methods (A and B) , two brands of ATV tablet were selected, injected and the effect of excipients were studied in respect to retention time, capacity factor, tailing factor and no. of theoretical plates. The method is very much specific as there is no interference of excipients (Figure 4, 5, 6, 7) . 
Statistical Correlation
To test difference between the proposed HPLC methods statistical tests were performed for the level of confidence 95% (P = 0.05).Two way ANOVA was applied to test both method -sample interaction and differences in method precision. In both the cases F stat is less than F crit, signifying the method -sample interaction and the differences between the methods are not significant (Table 5 ). To test means a paired student's ttest was applied. The test removes any variation between samples. From the student's ttest, t Stat < t critical was found in both the cases signifying there is no significant difference between the means (Table 6 ). 
Conclusion
A simple, precise, selective and sensitive isocratic HPLC assay method with UV detection for ATV in pharmaceutical dosage form has been developed and validated. The advantage of the method is that it can be applicable for quantification of ATV at two wavelengths which indicates the specificity of the method. Statistical analysis signifies that there is no difference between the two methods, so gives a universal applicability of the methods for quality control of Atazanavir Sulfate in raw materials and dosage form.
